UBS lowered the firm’s price target on Marvell (MRVL) to $115 from $120 and keeps a Buy rating on the shares. The firm trimmed estimates to account for near-term dilution from the Celestial AI acquisition.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRVL:
- Marvell price target lowered to $113 from $114 at Citi
- The VanEck Semiconductor ETF (SMH) News: Weekly Fund Flow Statistics – 1/27/26
- Option traders moderately bearish in Marvell with shares up 2.09%
- Microsoft launch ‘derivative positive’ for Marvell, Arista
- Trump Weekly: President sues JPMorgan, drops tariffs over Greenland